Financials

  • Market Capitalization 2.1 B
  • Employee 361
  • Founded 2016
  • CEO N/A
  • Website www.veratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00Q72WYG3
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-10.87
ratio cours/chiffre d'affaires
7 992.14

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1887
AUPH
Aurinia Pharmaceuticals Inc - Common Shares
16.58 USD-0.42%+4.94%+2.73%+38.98%2.21 B USD
1893
BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock
8.44 USD-1.29%+5.76%+3.30%+16.74%2.16 B USD
1916
VRDN
Viridian Therapeutics, Inc. - Common Stock
19.07 USD+2.20%+0.26%-11.18%-15.06%2.16 B USD
1920
NVAX
Novavax, Inc. - Common Stock
12.72 USD-0.24%+21.37%+35.03%+51.07%2.10 B USD

Nouvelles